Engineering PTEN-L for Cell-Mediated Delivery.

Lavictoire, Sylvie J; Gont, Alexander; Julian, Lisa M; Stanford, William L; Vlasschaert, Caitlyn; Gray, Douglas A; Jomaa, Danny; Lorimer, Ian A J.

Afiliação

Lavictoire SJ; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.
Gont A; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.
Julian LM; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Stanford WL; Regenerative Medicine Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.
Vlasschaert C; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Gray DA; Regenerative Medicine Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.
Jomaa D; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Lorimer IAJ; Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON K1H 8L6, Canada.

Mol Ther Methods Clin Dev ; 9: 12-22, 2018 Jun 15.

Article em En | MEDLINE | ID: mdl-29255742